Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 8,737-8,748 of 10,592

Drug study icon

CompletedNCT01472991

Safety & Efficacy of TC-5619 in Adults With Inattentive-predominant Attention Deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Targacept Inc.
Condition: ADHD

Drug study icon

CompletedNCT00856973

Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 6 Years to 17 Years

Countries: United States
Sponsor: Sumitomo Pharma America, Inc.
Condition: ADHD

Drug study icon

CompletedNCT00204386

Safety & Efficacy Study Using Topiramate in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: University of Oklahoma
Condition: PTSD

Drug study icon

CompletedNCT00151983

Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy

This study is completed in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 6 Years to 12 Years

Countries: United States
Sponsor: Noven Therapeutics
Condition: ADHD

Behavioral study icon

CompletedNCT04515784

Safety Aid Reduction Treatment for PTSD Among Veterans

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralOver 18 Years

Countries: United States
Sponsor: VA Office of Research and Development
Condition: PTSD

Drug study icon

CompletedNCT00968851

Safety and Cognitive Function Study of EVP-6124 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States, Russia, Serbia, ...
Sponsor: FORUM Pharmaceuticals Inc
Condition: Schizophrenia

Drug study icon

CompletedNCT00322023

Safety and Effectiveness of D-serine in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Schizophrenia

Other study type icon

CompletedNCT01849809

Safety and Effectiveness of Gamma Capsulotomy in Intractable OCD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

OCDOtherFrom 18 Years to 65 Years

Countries: United States
Sponsor: Butler Hospital
Condition: OCD

Device study icon

CompletedNCT02586688

Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDeviceFrom 12 Years to 21 Years

Countries: United States
Sponsor: Neuronetics
Condition: Depression

Drug study icon

CompletedNCT00307203

Safety and Effectiveness of Sustained Release Bupropion in Treating Individuals With Schizophrenia Who Smoke

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: National Institute on Drug Abuse (NIDA)
Condition: Schizophrenia

Drug study icon

TerminatedNCT05181995

Safety and Efficacy of 50 mg NYX-783 QD vs. Placebo in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugOver 18 Years

Countries: United States
Sponsor: Aptinyx
Condition: PTSD

Drug study icon

CompletedNCT00507065

Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

This study is completed in the United States. It focuses on ADHD.

In United States

ADHDDrugFrom 13 Years to 17 Years

Countries: United States
Sponsor: Shire
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.